Early radiological assessment of locally advanced pancreatic cancer treated with electrochemotherapy

被引:1
|
作者
Vincenza Granata [1 ]
Roberta Fusco [1 ]
Sergio Venanzio Setola [1 ]
Mauro Piccirillo [2 ]
Maddalena Leongito [2 ]
Raffaele Palaia [2 ]
Francesco Granata [3 ]
Secondo Lastoria [1 ]
Francesco Izzo [2 ]
Antonella Petrillo [1 ]
机构
[1] Department of Diagnostic Imaging, Radiant and Metabolic Therapy, “Istituto Nazionale Tumori IRCCS Fondazione Pascale - IRCCS di Napoli”
[2] Department of Surgical Oncology, Hepatobiliary Unit, “Istituto Nazionale Tumori IRCCS Fondazione Pascale - IRCCS di Napoli”
[3] Departement of Civil and Mechanical Engineering, “University of Cassino and Southern Lazio”,Viale dell'Università
关键词
Reversible electroporation; Response assessment; Positron emission tomography/computed tomography; Pancreatic cancer; Magnetic resonance imaging;
D O I
暂无
中图分类号
R735.9 [胰腺肿瘤];
学科分类号
100214 ;
摘要
AIM To report early imaging assessment of ablated area post electrochemotherapy(ECT) in patients with locally advanced pancreatic cancer(LAPC). METHODS ECT was performed in 19 LAPC patients enrolled in an approved ongoing clinical phase Ⅰ/Ⅱ study. Before and after ECT, 18 patients underwent computed tomography(CT) scan, 11 patients underwent morphological and functional magnetic resonance(MR) scan(dynamic contrast enhanced-MRI) calculating wash-in slope(WIS) and wash-out slope(WOS); diffusion weighted imaging calculating pseudo-diffusivity(Dp), perfusion fraction(fp) and tissue diffusivity(Dt); 10 patients underwentpositron emission tomography(PET). Response evaluation criteria in solid tumour(RECIST) on MR and CT were used to assess tumour therapy response. Choi on CT, PET response criteria in solid tumors(PERCIST) on PET and functional parameters on MR were used to evaluate treatment response.RESULTS For each patient no significant reduction was measurable by CT and MR using RECIST. According Choi criteria a partial response was obtained in 18/18(100.0%) patients. According PERCIST criteria 6/10(60.0%) patients showed a partial response, 3/10(30.0%) stable disease and 1/10(10.0%) progression disease. Moreover, using functional MR parameters, a significant reduction of viable tumour after ECT can be observed. According ΔWIS and ΔWOS 9/11(81.8%) patients exhibited a partial response and 2/11(18.2%) stable disease; 8/11(72.7%) patients were considered in partial response by ΔDp evaluation and 3/11(27.3%) in stable disease; according ΔDt 7/11(63.6%) patients showed a partial response, 1/11(9.1%) showed progression of disease and 3/11(27.3%) were stable. Perfusion fraction fp showed a significant reduction after ECT only in four patients. No significant difference was observed after ECT in signal intensity of T1-weighted images and T2-weighted images, and in equilibrium-phase of contrast study, according to χ2 test was observed. A good correlation was reported between ΔHounsfield unit and Δmaximum standardized uptake value and between Δfp and ΔWOS, with a significant statistically difference(P < 0.05) using Spearman correlation coefficient.CONCLUSION Perfusion and diffusion MR derived parameters, Choi, PERCIST criteria are more performant than morphological MR and CT criteria to assess ECT treatment response.
引用
收藏
页码:4767 / 4778
页数:12
相关论文
共 50 条
  • [1] Early radiological assessment of locally advanced pancreatic cancer treated with electrochemotherapy
    Granata, Vincenza
    Fusco, Roberta
    Setola, Sergio Venanzio
    Piccirillo, Mauro
    Leongito, Maddalena
    Palaia, Raffaele
    Granata, Francesco
    Lastoria, Secondo
    Izzo, Francesco
    Petrillo, Antonella
    WORLD JOURNAL OF GASTROENTEROLOGY, 2017, 23 (26) : 4767 - 4778
  • [2] Comments on "The beneficial role of electrochemotherapy in locally advanced pancreatic cancer - radiological perspective"
    Granata, Vincenza
    Palaia, Raffaele
    Izzo, Francesco
    POLISH JOURNAL OF RADIOLOGY, 2022, 87 : E1 - E2
  • [3] Benefitial role of electrochemotherapy in locally advanced pancreatic cancer-radiological perspective
    Kozak, Oliwia
    Hac, Stanislaw
    Pienkowska, Joanna
    Studniarek, Michal
    POLISH JOURNAL OF RADIOLOGY, 2022, 87 : E30 - E42
  • [4] Electrochemotherapy in locally advanced pancreatic cancer: Preliminary results
    Granata, V.
    Fusco, R.
    Piccirillo, M.
    Palaia, R.
    Petrillo, A.
    Lastoria, S.
    Izzo, F.
    INTERNATIONAL JOURNAL OF SURGERY, 2015, 18 : 230 - 236
  • [5] Clinical Phase I/II Study: Local Disease Control and Survival in Locally Advanced Pancreatic Cancer Treated with Electrochemotherapy
    Izzo, Francesco
    Granata, Vincenza
    Fusco, Roberta
    D'Alessio, Valeria
    Petrillo, Antonella
    Lastoria, Secondo
    Piccirillo, Mauro
    Albino, Vittorio
    Belli, Andrea
    Tafuto, Salvatore
    Avallone, Antonio
    Patrone, Renato
    Palaia, Raffaele
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (06) : 1 - 18
  • [6] Prognostic factors for locally advanced pancreatic cancer treated with chemoradiation
    Rudra, S.
    Swartz, M. J.
    Asrari, F.
    Laheru, D. A.
    Pawlik, T. J.
    Cavallio, K.
    Herman, J. M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 69 (03): : S302 - S302
  • [7] Intraoperative electrochemotherapy in locally advanced pancreatic cancer: indications, techniques and results—a single-center experience
    Riccardo Casadei
    Claudio Ricci
    Carlo Ingaldi
    Laura Alberici
    Mariacristina Di Marco
    Alessandra Guido
    Francesco Minni
    Carla Serra
    Updates in Surgery, 2020, 72 : 1089 - 1096
  • [8] Locally advanced pancreatic cancer
    Willett, CG
    Czito, BG
    Bendell, JC
    Ryan, DP
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (20) : 4538 - 4544
  • [9] Locally Advanced, Unresectable Pancreatic Cancer Treated by Stereotactic Radiation Therapy
    Choi, Chul-Won
    Kim, Mi-Sook
    Cho, Chul-Koo
    Yoo, Seong-Yul
    Yang, Kwang-Mo
    Yoo, Hyung-Jun
    Lee, Dong-Han
    Ji, Young-Hoon
    Han, Chul-Ju
    Kim, Jin
    Kim, Young-Han
    RADIATION ONCOLOGY JOURNAL, 2006, 24 (01): : 11 - 20
  • [10] Locally advanced pancreatic cancer treated with radiation and 5-fluorouracil
    Mawdsley, S
    Hall, M
    Glynne-Jones, R
    CLINICAL ONCOLOGY, 2002, 14 (04) : 308 - 312